Savara Pharmaceuticals
SVRA
#6301
Rank
A$0.91 B
Marketcap
$5.58
Share price
4.72%
Change (1 day)
3.86%
Change (1 year)

EPS for Savara Pharmaceuticals (SVRA)

EPS in 2023 (TTM): -$0.42

According to Savara Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$0.41. In 2022 the company made an earnings per share (EPS) of -$0.37 an increase over its 2021 EPS that were of -$0.50.

EPS history for Savara Pharmaceuticals from 2002 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.4213.53%
2022-$0.37-26.47%
2021-$0.50-59.52%
2020-$1.24-56.48%
2019-$2.862.66%
2018-$2.78-38.56%
2017-$4.53-71.06%
2016-$15.66-37.06%
2015-$24.884.35%
2014-$23.84-25.81%
2013-$32.13-8.82%
2012-$35.24-27.66%
2011-$48.72-58.41%
2010-$117.14-86%
2009-$836.544.13%
2008-$803.3724%
2007-$647.88-35.9%
2006-$1,01195%
2005-$518.3053.85%
2004-$336.9044.44%
2003-$233.24-40%
2002-$388.73

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$1.48 257.14%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.40-3.57%๐Ÿ‡บ๐Ÿ‡ธ USA